Drug
Pitavastatin 4mg
Pitavastatin 4mg is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
active_not_recruiting125%
completed250%
unknown125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_4
Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides
NCT07442630
unknown
The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment
NCT04270344
completedphase_4
Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
NCT02545231
completedphase_4
Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers
NCT01043094
Clinical Trials (4)
Showing 4 of 4 trials
NCT07442630Phase 4
Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides
NCT04270344
The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment
NCT02545231Phase 4
Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
NCT01043094Phase 4
Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4